25 XP   0   0   10

Ionis Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyse Ionis Pharmaceuticals Inc together

PenkeI guess you are interested in Ionis Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Ionis Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Ionis Pharmaceuticals Inc

I send you an email if I find something interesting about Ionis Pharmaceuticals Inc.

Quick analysis of Ionis Pharmaceuticals Inc (30 sec.)










What can you expect buying and holding a share of Ionis Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
7.5%

What is your share worth?

Current worth
$2.65
Expected worth in 1 year
$1.37
How sure are you?
47.5%

+ What do you gain per year?

Total Gains per Share
$-1.28
Return On Investment
-2.9%

For what price can you sell your share?

Current Price per Share
$43.35
Expected price per share
$41.60 - $48.05
How sure are you?
50%

1. Valuation of Ionis Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)

$43.35

Intrinsic Value Per Share

$-29.26 - $7.26

Total Value Per Share

$-26.60 - $9.91

2. Growth of Ionis Pharmaceuticals Inc (5 min.)




Is Ionis Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$386.6m$625.4m-$221.2m-54.7%

How much money is Ionis Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$91.3m-$67.3m-$23.9m-26.3%
Net Profit Margin-61.2%-47.0%--

How much money comes from the company's main activities?

3. Financial Health of Ionis Pharmaceuticals Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#143 / 1031

Most Revenue
#58 / 1031

Most Profit
#985 / 1031

Most Efficient
#571 / 1031

What can you expect buying and holding a share of Ionis Pharmaceuticals Inc? (5 min.)

Welcome investor! Ionis Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Ionis Pharmaceuticals Inc.

What can you expect buying and holding a share of Ionis Pharmaceuticals Inc?

First you should know what it really means to hold a share of Ionis Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Ionis Pharmaceuticals Inc is $43.35. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ionis Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ionis Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.65. Based on the TTM, the Book Value Change Per Share is $-0.32 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.22 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ionis Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.06-0.1%-0.63-1.4%-0.46-1.1%-0.29-0.7%-0.14-0.3%
Usd Book Value Change Per Share0.491.1%-0.32-0.7%-0.22-0.5%-0.26-0.6%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.020.0%0.010.0%
Usd Total Gains Per Share0.491.1%-0.32-0.7%-0.22-0.5%-0.25-0.6%0.010.0%
Usd Price Per Share50.59-43.18-39.02-47.68-47.18-
Price to Earnings Ratio-199.01--59.56--23.52--154.27--142.62-
Price-to-Total Gains Ratio102.86--29.39-76.68-60.79-4.89-
Price to Book Ratio19.07-16.18-9.17-9.33-17.86-
Price-to-Total Gains Ratio102.86--29.39-76.68-60.79-4.89-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share43.35
Number of shares23
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.02
Usd Book Value Change Per Share-0.32-0.26
Usd Total Gains Per Share-0.32-0.25
Gains per Quarter (23 shares)-7.35-5.65
Gains per Year (23 shares)-29.40-22.59
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-29-392-24-33
20-59-683-48-56
30-88-975-73-79
40-118-1267-97-102
50-147-1558-121-125
60-176-18410-145-148
70-206-21312-170-171
80-235-24213-194-194
90-265-27115-218-217
100-294-30017-242-240

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%4.016.00.020.0%11.029.00.027.5%15.0117.00.011.4%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%9.011.00.045.0%19.021.00.047.5%50.081.01.037.9%
Dividend per Share0.00.04.00.0%2.00.010.016.7%3.00.017.015.0%3.00.037.07.5%3.00.0129.02.3%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%9.011.00.045.0%19.021.00.047.5%50.081.01.037.9%

Fundamentals of Ionis Pharmaceuticals Inc

About Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an antisense injection for the treatment of polyneuropathy caused by hereditary transthyretin amyloidosis in adults; and WAYLIVRA, an antisense medicine for treatment for familial chylomicronemia syndrome (FCS) and familial partial lipodystrophy. It also develops medicines for various indications that are in phase 3 study, including Eplontersen as a monthly self-administered subcutaneous injection to treat all types of ATTR; Olezarsen for patients with FCS and severe hypertriglyceridemia (SHTG); Donidalorsen for patients with hereditary angioedema; ION363 for patients with amyotrophic lateral sclerosis; Tofersen to inhibit the production of superoxide dismutase 1; Pelacarsen for patients with established cardiovascular disease and elevated lipoprotein(a); and Bepirovirsen to inhibit the production of viral proteins associated with hepatitis B virus. In addition, the company develops IONIS-FB-LRx to inhibit the production of complement factor B and the alternative complement pathway; and ION224 to reduce the production of diacylglycerol acyltransferase 2. It has a strategic collaboration with Biogen for the treatment of neurological disorders; and collaboration and license agreement with Metagenomi, Inc, AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis, Roche, Swedish Orphan Biovitrum AB, and PTC Therapeutics. The company was incorporated in 1989 and is based in Carlsbad, California.

Fundamental data was last updated by Penke on 2024-03-20 21:22:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Ionis Pharmaceuticals Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Ionis Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Ionis Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -2.9% means that $-0.03 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ionis Pharmaceuticals Inc:

  • The MRQ is -2.9%. The company is making a loss. -1
  • The TTM is -61.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-2.9%TTM-61.2%+58.3%
TTM-61.2%YOY-47.0%-14.2%
TTM-61.2%5Y-35.1%-26.1%
5Y-35.1%10Y-31.0%-4.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.9%-159.2%+156.3%
TTM-61.2%-202.3%+141.1%
YOY-47.0%-263.0%+216.0%
5Y-35.1%-452.4%+417.3%
10Y-31.0%-589.0%+558.0%
1.1.2. Return on Assets

Shows how efficient Ionis Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ionis Pharmaceuticals Inc to the Biotechnology industry mean.
  • -0.3% Return on Assets means that Ionis Pharmaceuticals Inc generated $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ionis Pharmaceuticals Inc:

  • The MRQ is -0.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.3%TTM-3.1%+2.8%
TTM-3.1%YOY-2.7%-0.4%
TTM-3.1%5Y-1.7%-1.4%
5Y-1.7%10Y-1.2%-0.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.3%-12.5%+12.2%
TTM-3.1%-12.2%+9.1%
YOY-2.7%-11.2%+8.5%
5Y-1.7%-13.3%+11.6%
10Y-1.2%-14.6%+13.4%
1.1.3. Return on Equity

Shows how efficient Ionis Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ionis Pharmaceuticals Inc to the Biotechnology industry mean.
  • -2.4% Return on Equity means Ionis Pharmaceuticals Inc generated $-0.02 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ionis Pharmaceuticals Inc:

  • The MRQ is -2.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -23.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.4%TTM-23.6%+21.2%
TTM-23.6%YOY-10.7%-12.8%
TTM-23.6%5Y-8.9%-14.7%
5Y-8.9%10Y-6.7%-2.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.4%-16.0%+13.6%
TTM-23.6%-15.8%-7.8%
YOY-10.7%-13.9%+3.2%
5Y-8.9%-18.2%+9.3%
10Y-6.7%-19.1%+12.4%

1.2. Operating Efficiency of Ionis Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Ionis Pharmaceuticals Inc is operating .

  • Measures how much profit Ionis Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ionis Pharmaceuticals Inc to the Biotechnology industry mean.
  • An Operating Margin of -2.2% means the company generated $-0.02  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ionis Pharmaceuticals Inc:

  • The MRQ is -2.2%. The company is operating very inefficient. -2
  • The TTM is -55.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-2.2%TTM-55.7%+53.5%
TTM-55.7%YOY-69.6%+13.8%
TTM-55.7%5Y-33.9%-21.8%
5Y-33.9%10Y-31.4%-2.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.2%-299.5%+297.3%
TTM-55.7%-208.5%+152.8%
YOY-69.6%-280.2%+210.6%
5Y-33.9%-459.9%+426.0%
10Y-31.4%-596.9%+565.5%
1.2.2. Operating Ratio

Measures how efficient Ionis Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.02 means that the operating costs are $1.02 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Ionis Pharmaceuticals Inc:

  • The MRQ is 1.019. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.592. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.019TTM1.592-0.573
TTM1.592YOY1.696-0.104
TTM1.5925Y1.342+0.249
5Y1.34210Y1.858-0.515
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0192.817-1.798
TTM1.5923.181-1.589
YOY1.6963.609-1.913
5Y1.3425.554-4.212
10Y1.8587.396-5.538

1.3. Liquidity of Ionis Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Ionis Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 5.90 means the company has $5.90 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Ionis Pharmaceuticals Inc:

  • The MRQ is 5.896. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.830. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.896TTM3.830+2.065
TTM3.830YOY8.174-4.344
TTM3.8305Y7.908-4.078
5Y7.90810Y7.308+0.600
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.8963.987+1.909
TTM3.8304.440-0.610
YOY8.1745.569+2.605
5Y7.9086.158+1.750
10Y7.3086.492+0.816
1.3.2. Quick Ratio

Measures if Ionis Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ionis Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Quick Ratio of 9.73 means the company can pay off $9.73 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ionis Pharmaceuticals Inc:

  • The MRQ is 9.732. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.404. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ9.732TTM6.404+3.328
TTM6.404YOY13.428-7.023
TTM6.4045Y13.031-6.626
5Y13.03110Y11.695+1.336
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.7323.653+6.079
TTM6.4044.158+2.246
YOY13.4285.515+7.913
5Y13.0316.012+7.019
10Y11.6956.206+5.489

1.4. Solvency of Ionis Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Ionis Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ionis Pharmaceuticals Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.87 means that Ionis Pharmaceuticals Inc assets are financed with 87.1% credit (debt) and the remaining percentage (100% - 87.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Ionis Pharmaceuticals Inc:

  • The MRQ is 0.871. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.863. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.871TTM0.863+0.008
TTM0.863YOY0.748+0.115
TTM0.8635Y0.673+0.190
5Y0.67310Y0.693-0.020
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8710.336+0.535
TTM0.8630.330+0.533
YOY0.7480.267+0.481
5Y0.6730.367+0.306
10Y0.6930.378+0.315
1.4.2. Debt to Equity Ratio

Measures if Ionis Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ionis Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 673.3% means that company has $6.73 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ionis Pharmaceuticals Inc:

  • The MRQ is 6.733. The company is unable to pay all its debts with equity. -1
  • The TTM is 6.478. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ6.733TTM6.478+0.254
TTM6.478YOY2.995+3.483
TTM6.4785Y2.947+3.531
5Y2.94710Y3.084-0.137
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.7330.376+6.357
TTM6.4780.398+6.080
YOY2.9950.334+2.661
5Y2.9470.431+2.516
10Y3.0840.476+2.608

2. Market Valuation of Ionis Pharmaceuticals Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Ionis Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Ionis Pharmaceuticals Inc to the Biotechnology industry mean.
  • A PE ratio of -199.01 means the investor is paying $-199.01 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ionis Pharmaceuticals Inc:

  • The EOD is -170.527. Based on the earnings, the company is expensive. -2
  • The MRQ is -199.007. Based on the earnings, the company is expensive. -2
  • The TTM is -59.564. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-170.527MRQ-199.007+28.480
MRQ-199.007TTM-59.564-139.443
TTM-59.564YOY-23.522-36.042
TTM-59.5645Y-154.272+94.708
5Y-154.27210Y-142.624-11.648
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-170.527-2.697-167.830
MRQ-199.007-2.422-196.585
TTM-59.564-2.709-56.855
YOY-23.522-4.116-19.406
5Y-154.272-6.257-148.015
10Y-142.624-6.478-136.146
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Ionis Pharmaceuticals Inc:

  • The EOD is 46.894. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 54.726. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 4.382. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD46.894MRQ54.726-7.832
MRQ54.726TTM4.382+50.344
TTM4.382YOY-38.986+43.368
TTM4.3825Y-24.847+29.229
5Y-24.84710Y69.551-94.398
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD46.894-3.344+50.238
MRQ54.726-2.939+57.665
TTM4.382-3.486+7.868
YOY-38.986-5.592-33.394
5Y-24.847-8.464-16.383
10Y69.551-8.872+78.423
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Ionis Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 19.07 means the investor is paying $19.07 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Ionis Pharmaceuticals Inc:

  • The EOD is 16.340. Based on the equity, the company is expensive. -2
  • The MRQ is 19.069. Based on the equity, the company is expensive. -2
  • The TTM is 16.181. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD16.340MRQ19.069-2.729
MRQ19.069TTM16.181+2.887
TTM16.181YOY9.175+7.007
TTM16.1815Y9.334+6.847
5Y9.33410Y17.862-8.528
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD16.3402.198+14.142
MRQ19.0692.042+17.027
TTM16.1812.121+14.060
YOY9.1752.907+6.268
5Y9.3343.682+5.652
10Y17.8624.114+13.748
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Ionis Pharmaceuticals Inc.

3.1. Institutions holding Ionis Pharmaceuticals Inc

Institutions are holding 100.939% of the shares of Ionis Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31FMR Inc14.76540.083621520872219500.1021
2023-12-31Vanguard Group Inc9.7450.015714203481-298544-2.0586
2023-12-31T. Rowe Price Investment Management,Inc.9.05750.434313201453783980.5974
2023-12-31BlackRock Inc6.21440.01179057530-57097-0.6264
2023-12-31Bellevue Group AG5.97866.74338713987-519713-5.6284
2023-12-31ClearBridge Advisors, LLC3.22980.20494707480-133215-2.752
2023-12-31Wellington Management Company LLP3.16770.043646169782856353162.2352
2023-12-31T. Rowe Price Associates, Inc.2.91940.0289425507449707713.2272
2023-12-31State Street Corporation2.75040.00994008797537681.3595
2023-09-30Bvf Inc2.74764.89834004613115859840.7095
2023-12-31Pictet Asset Manangement SA2.41390.196335183172773838.5587
2023-12-31Tweedy, Browne Co LLC2.37028.53133454676-55497-1.581
2023-12-31Macquarie Group Ltd2.11880.180530882351523115.1878
2023-12-31Geode Capital Management, LLC1.56150.01212275931812003.6998
2023-12-31Orbimed Advisors, LLC1.41672.08612064797-104703-4.8261
2023-12-31ARK Investment Management LLC1.30710.57061905056-461311-19.4945
2023-12-31Farallon Capital Management, L.L.C.1.06690.39051555020828020113.8955
2023-12-31Adage Capital Partners Gp LLC0.95050.1451138530031830029.8313
2023-12-31Charles Schwab Investment Management Inc0.8750.01641275319330122.6573
2023-12-31Deep Track Capital, LP0.8572.11031249068-1585001-55.9267
Total 75.513426.7134110061984+3141289+2.9%

3.2. Funds holding Ionis Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-01-31Fidelity Growth Compy Commingled Pl O6.39330.667793184031743861.9071
2023-09-30BB Biotech AG Ord6.243516.88729100000-199700-2.1474
2024-01-31Fidelity Growth Company Fund4.650.63516777482-64369-0.9408
2023-12-31T. Rowe Price Mid-Cap Growth3.23440.78754714200-11200-0.237
2023-12-31T. Rowe Price US Mid-Cap Growth Equity3.23440.7854714200-11200-0.237
2024-02-29Vanguard Total Stock Mkt Idx Inv2.93050.01254271184-11923-0.2784
2024-02-29Vanguard Small Cap Index2.41030.1133513074324070.9311
2023-12-31Vanguard Health Care Inv1.98820.315928978281758405154.3242
2023-12-31Tweedy, Browne International Value Fund1.77652.2403258931600
2024-01-31Fidelity Growth Company K61.65860.74122417506-60017-2.4225
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.45380.0939211887143480.2056
2024-01-31Fidelity Series Growth Company1.40580.7086204896900
2024-02-29Vanguard Small Cap Growth Index Inv1.35290.25551971934303651.5639
2023-12-31ARK Genomic Revolution1.29474.29881887080-458312-19.541
2023-12-31ClearBridge Aggressive Growth A1.20561.9851175723700
2024-02-29SPDR® S&P Biotech ETF1.18910.98951733140324001.9051
2024-01-31ClearBridge Aggressive Growth1.13571.89841655237-102000-5.8046
2024-02-29ARK Genomic Revolution ETF1.00913.556147077574340.508
2023-12-31Ivy Science/Technology Composite0.91951.2966134022200
2023-12-31Delaware Ivy Science and Technology C0.91951.2953134022200
Total 46.405439.563167636880+1121024+1.7%

3.3. Insider Transactions

Insiders are holding 0.86% of the shares of Ionis Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-02-16Brett P MoniaSELL38744.49
2024-02-02Brett P MoniaSELL2350149.37
2024-02-02Elizabeth L HougenSELL212549.54
2024-02-02Eric SwayzeSELL190749.56
2024-01-31Eric SwayzeSELL1077352
2024-01-25Brett P MoniaSELL228551.75
2024-01-25Patrick R O'neilSELL645051.75
2024-01-17Brett P MoniaSELL3205950.42
2024-01-17Elizabeth L HougenSELL868350.42
2024-01-17Onaiza Cadoret-manierSELL556450.42
2024-01-12Eugene SchneiderSELL800053.5
2023-12-28B Lynne ParshallSELL4252550.19
2023-12-26B Lynne ParshallSELL2511351.46
2023-12-26Patrick R O'neilSELL2082551.46
2023-12-21Brett P MoniaSELL1750049.29
2023-12-20C Frank BennettSELL650049.64
2023-12-14Brett P MoniaSELL2400049.58
2023-11-15Joseph Klein IiiSELL200050
2023-10-17Eric SwayzeSELL5247.95
2023-10-12Brett P MoniaSELL377046

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Ionis Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.492-0.320+165%-0.223+145%-0.263+154%0.001+34464%
Book Value Per Share--2.6532.773-4%4.291-38%6.236-57%4.371-39%
Current Ratio--5.8963.830+54%8.174-28%7.908-25%7.308-19%
Debt To Asset Ratio--0.8710.863+1%0.748+16%0.673+29%0.693+26%
Debt To Equity Ratio--6.7336.478+4%2.995+125%2.947+128%3.084+118%
Dividend Per Share----0%0.002-100%0.018-100%0.009-100%
Eps---0.064-0.628+887%-0.463+628%-0.292+359%-0.138+117%
Free Cash Flow Per Share--0.231-0.574+348%-0.505+319%-0.118+151%0.044+425%
Free Cash Flow To Equity Per Share--0.5110.531-4%-0.600+218%0.000+622052%0.240+113%
Gross Profit Margin--1.0001.0010%1.0040%1.0010%1.0000%
Intrinsic Value_10Y_max--7.261--------
Intrinsic Value_10Y_min---29.257--------
Intrinsic Value_1Y_max--0.256--------
Intrinsic Value_1Y_min---1.713--------
Intrinsic Value_3Y_max--1.129--------
Intrinsic Value_3Y_min---6.232--------
Intrinsic Value_5Y_max--2.435--------
Intrinsic Value_5Y_min---11.908--------
Market Cap6318349200.000-17%7373593680.0006293571360.000+17%5686514280.000+30%6992953400.000+5%6903583432.000+7%
Net Profit Margin---0.029-0.612+2044%-0.470+1548%-0.351+1131%-0.310+987%
Operating Margin---0.022-0.557+2384%-0.696+3000%-0.339+1413%-0.314+1301%
Operating Ratio--1.0191.592-36%1.696-40%1.342-24%1.858-45%
Pb Ratio16.340-17%19.06916.181+18%9.175+108%9.334+104%17.862+7%
Pe Ratio-170.527+14%-199.007-59.564-70%-23.522-88%-154.272-22%-142.624-28%
Price Per Share43.350-17%50.59043.180+17%39.015+30%47.680+6%47.178+7%
Price To Free Cash Flow Ratio46.894-17%54.7264.382+1149%-38.986+171%-24.847+145%69.551-21%
Price To Total Gains Ratio88.139-17%102.860-29.395+129%76.680+34%60.789+69%4.894+2002%
Quick Ratio--9.7326.404+52%13.428-28%13.031-25%11.695-17%
Return On Assets---0.003-0.031+907%-0.027+776%-0.017+443%-0.012+298%
Return On Equity---0.024-0.236+885%-0.107+349%-0.089+271%-0.067+180%
Total Gains Per Share--0.492-0.320+165%-0.221+145%-0.245+150%0.010+4630%
Usd Book Value--386686000.000404171500.000-4%625415250.000-38%916304850.000-58%641654250.000-40%
Usd Book Value Change Per Share--0.492-0.320+165%-0.223+145%-0.263+154%0.001+34464%
Usd Book Value Per Share--2.6532.773-4%4.291-38%6.236-57%4.371-39%
Usd Dividend Per Share----0%0.002-100%0.018-100%0.009-100%
Usd Eps---0.064-0.628+887%-0.463+628%-0.292+359%-0.138+117%
Usd Free Cash Flow--33684000.000-83683000.000+348%-73617250.000+319%-15601050.000+146%7260800.000+364%
Usd Free Cash Flow Per Share--0.231-0.574+348%-0.505+319%-0.118+151%0.044+425%
Usd Free Cash Flow To Equity Per Share--0.5110.531-4%-0.600+218%0.000+622052%0.240+113%
Usd Market Cap6318349200.000-17%7373593680.0006293571360.000+17%5686514280.000+30%6992953400.000+5%6903583432.000+7%
Usd Price Per Share43.350-17%50.59043.180+17%39.015+30%47.680+6%47.178+7%
Usd Profit---9263000.000-91315750.000+886%-67323000.000+627%-41008700.000+343%-19155525.000+107%
Usd Revenue--324505000.000196876250.000+65%146869250.000+121%201876050.000+61%149733600.000+117%
Usd Total Gains Per Share--0.492-0.320+165%-0.221+145%-0.245+150%0.010+4630%
 EOD+3 -5MRQTTM+23 -11YOY+23 -135Y+23 -1310Y+24 -12

4.2. Fundamental Score

Let's check the fundamental score of Ionis Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-170.527
Price to Book Ratio (EOD)Between0-116.340
Net Profit Margin (MRQ)Greater than0-0.029
Operating Margin (MRQ)Greater than0-0.022
Quick Ratio (MRQ)Greater than19.732
Current Ratio (MRQ)Greater than15.896
Debt to Asset Ratio (MRQ)Less than10.871
Debt to Equity Ratio (MRQ)Less than16.733
Return on Equity (MRQ)Greater than0.15-0.024
Return on Assets (MRQ)Greater than0.05-0.003
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Ionis Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.380
Ma 20Greater thanMa 5043.513
Ma 50Greater thanMa 10046.682
Ma 100Greater thanMa 20048.287
OpenGreater thanClose44.950
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets2,990,072
Total Liabilities2,603,386
Total Stockholder Equity386,686
 As reported
Total Liabilities 2,603,386
Total Stockholder Equity+ 386,686
Total Assets = 2,990,072

Assets

Total Assets2,990,072
Total Current Assets2,641,853
Long-term Assets348,219
Total Current Assets
Cash And Cash Equivalents 399,266
Short-term Investments 1,931,935
Net Receivables 97,778
Inventory 28,425
Other Current Assets 184,449
Total Current Assets  (as reported)2,641,853
Total Current Assets  (calculated)2,641,853
+/-0
Long-term Assets
Property Plant Equipment 242,939
Long-term Assets Other 62,289
Long-term Assets  (as reported)348,219
Long-term Assets  (calculated)305,228
+/- 42,991

Liabilities & Shareholders' Equity

Total Current Liabilities448,090
Long-term Liabilities2,155,296
Total Stockholder Equity386,686
Total Current Liabilities
Short-term Debt 53,163
Short Long Term Debt 53,163
Accounts payable 26,027
Other Current Liabilities 217,772
Total Current Liabilities  (as reported)448,090
Total Current Liabilities  (calculated)350,125
+/- 97,965
Long-term Liabilities
Long term Debt 1,229,501
Capital Lease Obligations 170,875
Long-term Liabilities Other 513,736
Long-term Liabilities  (as reported)2,155,296
Long-term Liabilities  (calculated)1,914,112
+/- 241,184
Total Stockholder Equity
Common Stock144
Retained Earnings -1,795,911
Other Stockholders Equity 2,182,453
Total Stockholder Equity (as reported)386,686
Total Stockholder Equity (calculated)386,686
+/-0
Other
Capital Stock144
Cash and Short Term Investments 2,331,201
Common Stock Shares Outstanding 144,000
Current Deferred Revenue151,128
Liabilities and Stockholders Equity 2,990,072
Net Debt 1,054,273
Net Invested Capital 1,669,350
Net Working Capital 2,193,763
Property Plant and Equipment Gross 339,698
Short Long Term Debt Total 1,453,539



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-311995-09-301995-06-301995-03-311994-12-311994-09-301994-06-301994-03-311993-12-311993-09-301993-06-301993-03-311992-12-311992-09-301992-06-301992-03-311991-12-311991-09-301991-06-301991-03-311990-12-311990-09-301990-06-301990-03-31
> Total Assets 
0
0
0
4,300
19,000
43,600
40,400
73,600
68,500
65,000
60,700
55,500
67,200
62,400
60,400
78,800
80,300
73,900
71,300
66,600
60,200
58,300
80,500
99,600
98,700
91,600
84,900
101,300
97,800
99,100
97,300
117,900
101,300
117,600
106,800
96,100
82,900
95,300
94,100
103,100
151,844
177,024
176,575
183,256
163,364
187,528
294,412
417,061
417,061
443,226
424,524
438,683
415,095
370,856
353,546
334,942
312,726
279,962
255,271
208,425
175,648
146,526
177,382
166,373
150,637
201,919
187,768
255,907
349,904
263,255
213,003
258,858
405,424
609,399
584,692
574,150
724,506
709,161
680,578
657,184
599,723
606,351
575,858
550,477
505,942
529,572
505,785
484,894
470,807
472,394
485,681
545,686
552,961
788,651
881,916
847,156
834,616
817,777
793,803
955,809
955,433
976,258
988,005
956,105
875,819
811,109
843,586
912,467
1,083,996
1,090,831
1,252,561
1,322,024
1,299,560
2,247,315
2,247,913
2,667,784
2,835,889
2,878,000
2,894,989
3,233,000
3,090,913
3,078,950
3,095,701
2,390,000
2,248,551
2,497,069
2,414,893
2,612,000
2,519,092
2,456,133
2,421,971
2,534,000
2,885,000
2,971,000
2,934,000
2,990,072
2,990,0722,934,0002,971,0002,885,0002,534,0002,421,9712,456,1332,519,0922,612,0002,414,8932,497,0692,248,5512,390,0003,095,7013,078,9503,090,9133,233,0002,894,9892,878,0002,835,8892,667,7842,247,9132,247,3151,299,5601,322,0241,252,5611,090,8311,083,996912,467843,586811,109875,819956,105988,005976,258955,433955,809793,803817,777834,616847,156881,916788,651552,961545,686485,681472,394470,807484,894505,785529,572505,942550,477575,858606,351599,723657,184680,578709,161724,506574,150584,692609,399405,424258,858213,003263,255349,904255,907187,768201,919150,637166,373177,382146,526175,648208,425255,271279,962312,726334,942353,546370,856415,095438,683424,524443,226417,061417,061294,412187,528163,364183,256176,575177,024151,844103,10094,10095,30082,90096,100106,800117,600101,300117,90097,30099,10097,800101,30084,90091,60098,70099,60080,50058,30060,20066,60071,30073,90080,30078,80060,40062,40067,20055,50060,70065,00068,50073,60040,40043,60019,0004,300000
   > Total Current Assets 
0
0
0
1,900
16,200
37,100
33,200
62,800
55,300
50,800
44,400
38,500
49,100
42,800
40,000
55,600
58,400
52,200
49,400
45,000
39,100
37,500
60,200
79,000
76,900
70,200
62,700
79,400
73,200
72,600
70,200
89,200
71,800
87,200
75,600
63,200
48,900
51,000
48,500
59,200
97,725
126,188
128,772
133,204
116,187
110,941
220,301
328,816
328,816
348,456
319,644
320,180
294,663
271,954
255,242
239,561
208,881
182,292
159,355
125,609
96,991
72,367
114,242
105,858
90,731
148,274
136,923
206,203
296,067
210,777
161,387
207,317
352,851
555,180
529,543
518,384
663,692
647,512
619,247
596,126
530,415
536,885
507,550
483,137
437,395
410,720
377,089
360,139
347,613
350,419
361,586
423,438
431,829
669,061
763,304
735,510
722,053
705,797
681,163
836,597
835,427
855,452
868,261
837,003
763,910
697,971
730,329
797,932
962,372
964,359
1,111,113
1,167,984
1,143,283
2,083,272
2,079,224
2,207,886
2,373,949
2,415,000
2,408,091
2,721,000
2,558,045
2,531,187
2,536,981
2,130,000
1,989,418
2,238,418
2,155,740
2,345,000
2,253,124
2,191,148
2,152,126
2,203,000
2,543,000
2,616,000
2,585,000
2,641,853
2,641,8532,585,0002,616,0002,543,0002,203,0002,152,1262,191,1482,253,1242,345,0002,155,7402,238,4181,989,4182,130,0002,536,9812,531,1872,558,0452,721,0002,408,0912,415,0002,373,9492,207,8862,079,2242,083,2721,143,2831,167,9841,111,113964,359962,372797,932730,329697,971763,910837,003868,261855,452835,427836,597681,163705,797722,053735,510763,304669,061431,829423,438361,586350,419347,613360,139377,089410,720437,395483,137507,550536,885530,415596,126619,247647,512663,692518,384529,543555,180352,851207,317161,387210,777296,067206,203136,923148,27490,731105,858114,24272,36796,991125,609159,355182,292208,881239,561255,242271,954294,663320,180319,644348,456328,816328,816220,301110,941116,187133,204128,772126,18897,72559,20048,50051,00048,90063,20075,60087,20071,80089,20070,20072,60073,20079,40062,70070,20076,90079,00060,20037,50039,10045,00049,40052,20058,40055,60040,00042,80049,10038,50044,40050,80055,30062,80033,20037,10016,2001,900000
       Cash And Cash Equivalents 
0
0
0
1,800
15,600
33,600
18,100
21,200
16,000
13,200
14,600
16,500
27,000
21,700
17,900
33,700
33,200
18,400
16,200
12,900
16,600
18,800
24,800
46,500
22,600
25,500
25,800
37,100
26,200
35,900
28,900
38,100
27,800
38,900
38,000
27,600
20,300
34,400
38,300
35,300
64,733
62,043
59,030
39,615
8,057
12,736
12,311
127,011
127,011
110,017
93,079
101,856
61,092
85,318
55,792
33,117
39,757
30,371
21,446
27,250
12,006
7,988
53,222
3,650
1,711
105,359
104,238
114,514
183,423
132,964
102,398
138,614
271,936
445,720
264,682
217,918
254,057
215,789
149,293
105,255
98,590
46,038
100,122
70,052
86,200
85,022
55,263
65,477
56,391
85,645
84,563
374,446
107,650
296,540
256,408
656,761
161,778
94,081
73,220
728,832
148,348
754,934
126,593
779,183
703,804
112,534
84,275
665,223
114,221
855,709
159,184
1,022,715
1,035,301
805,490
479,891
2,084,072
375,811
2,262,000
247,939
2,500,000
486,195
530,181
633,059
1,892,000
414,155
565,119
632,953
2,115,000
542,513
521,917
314,993
1,987,000
309,031
424,790
352,060
399,266
399,266352,060424,790309,0311,987,000314,993521,917542,5132,115,000632,953565,119414,1551,892,000633,059530,181486,1952,500,000247,9392,262,000375,8112,084,072479,891805,4901,035,3011,022,715159,184855,709114,221665,22384,275112,534703,804779,183126,593754,934148,348728,83273,22094,081161,778656,761256,408296,540107,650374,44684,56385,64556,39165,47755,26385,02286,20070,052100,12246,03898,590105,255149,293215,789254,057217,918264,682445,720271,936138,614102,398132,964183,423114,514104,238105,3591,7113,65053,2227,98812,00627,25021,44630,37139,75733,11755,79285,31861,092101,85693,079110,017127,011127,01112,31112,7368,05739,61559,03062,04364,73335,30038,30034,40020,30027,60038,00038,90027,80038,10028,90035,90026,20037,10025,80025,50022,60046,50024,80018,80016,60012,90016,20018,40033,20033,70017,90021,70027,00016,50014,60013,20016,00021,20018,10033,60015,6001,800000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,500
17,500
29,001
58,291
61,655
87,647
100,337
93,562
200,891
185,007
185,007
215,119
198,944
187,497
208,359
170,614
179,028
182,387
141,116
116,973
104,119
76,633
70,778
51,592
48,435
90,739
76,850
32,581
22,633
78,819
102,131
69,769
43,593
55,105
66,479
91,249
247,341
273,080
398,179
421,722
458,547
469,057
420,529
475,990
397,782
402,301
340,622
310,162
309,500
278,187
277,553
250,384
259,010
33,622
309,124
356,402
479,494
52,096
533,101
553,432
566,192
81,881
640,152
60,604
704,193
24,792
19,703
559,773
612,955
2,414
746,060
722,718
851,624
893,085
807,796
1,174,960
1,479,098
1,805,252
1,877,943
1,989,508
1,972,891
1,816,257
1,897,892
1,818,435
1,696,145
1,494,711
1,405,840
1,494,151
1,354,146
1,245,782
1,509,880
1,499,910
1,666,670
1,710,397
2,037,750
1,960,598
1,883,522
1,931,935
1,931,9351,883,5221,960,5982,037,7501,710,3971,666,6701,499,9101,509,8801,245,7821,354,1461,494,1511,405,8401,494,7111,696,1451,818,4351,897,8921,816,2571,972,8911,989,5081,877,9431,805,2521,479,0981,174,960807,796893,085851,624722,718746,0602,414612,955559,77319,70324,792704,19360,604640,15281,881566,192553,432533,10152,096479,494356,402309,12433,622259,010250,384277,553278,187309,500310,162340,622402,301397,782475,990420,529469,057458,547421,722398,179273,080247,34191,24966,47955,10543,59369,769102,13178,81922,63332,58176,85090,73948,43551,59270,77876,633104,119116,973141,116182,387179,028170,614208,359187,497198,944215,119185,007185,007200,89193,562100,33787,64761,65558,29129,00117,5005,50000000000000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
100
0
39,800
0
0
0
0
0
0
0
0
0
1,600
1,900
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,500
5,300
7,300
3,800
5,400
3,064
4,644
6,942
3,346
4,800
2,098
4,097
10,360
10,360
12,010
10,881
14,906
4,981
2,725
2,749
2,657
5,774
9,593
5,464
10,048
2,911
4,456
4,209
3,918
3,503
2,618
2,959
2,395
2,057
2,296
9,237
6,177
4,358
6,399
5,021
4,121
2,351
783
586
10,899
1,904
5,040
1,341
1,242
591
5,674
1,858
6,921
1,379
1,558
3,476
522
1,172
2,024
12,645
11,102
9,823
41,941
26,313
3,903
26,934
3,264
1,826
11,356
16,480
746
8,544
108,043
69,357
50,615
42,924
62,955
36,858
16,761
14,732
12,759
10,452
32,000
49,077
63,000
28,605
27,834
38,977
76,000
23,397
24,004
9,068
62,000
26,122
6,751
6,645
26,000
14,000
28,000
142,000
97,778
97,778142,00028,00014,00026,0006,6456,75126,12262,0009,06824,00423,39776,00038,97727,83428,60563,00049,07732,00010,45212,75914,73216,76136,85862,95542,92450,61569,357108,0438,54474616,48011,3561,8263,26426,9343,90326,31341,9419,82311,10212,6452,0241,1725223,4761,5581,3796,9211,8585,6745911,2421,3415,0401,90410,8995867832,3514,1215,0216,3994,3586,1779,2372,2962,0572,3952,9592,6183,5033,9184,2094,4562,91110,0485,4649,5935,7742,6572,7492,7254,98114,90610,88112,01010,36010,3604,0972,0984,8003,3466,9424,6443,0645,4003,8007,3005,3003,50000000000000000001,9001,60000000000039,800010000000
       Other Current Assets 
0
0
0
100
600
3,400
15,100
1,800
39,300
37,600
29,800
22,000
22,100
21,100
22,100
21,900
25,200
32,200
31,300
32,100
22,500
18,700
35,400
32,500
54,300
44,700
36,900
42,300
47,000
36,700
41,300
51,100
44,000
48,300
37,600
32,100
23,300
9,300
900
1,000
927
1,210
1,145
2,596
2,993
2,545
3,002
6,438
6,438
11,310
3,666
4,831
5,768
6,733
8,380
7,405
7,686
9,281
8,236
8,956
8,574
7,260
7,459
6,600
7,918
6,830
6,461
9,614
7,363
4,238
4,229
4,604
6,378
7,113
6,988
20,547
6,514
6,439
8,004
8,147
6,791
7,023
6,309
7,058
7,376
7,613
7,553
5,415
7,417
5,724
7,800
15,370
8,074
5,786
7,372
26,653
9,814
8,567
8,353
25,884
13,154
39,914
29,066
33,028
40,403
17,250
15,236
22,252
25,933
58,035
48,930
82,314
71,124
76,994
97,125
111,055
98,686
121,000
118,809
158,000
122,468
131,015
146,628
162,000
123,827
131,045
136,643
168,000
150,577
142,759
143,173
190,000
182,000
203,000
207,000
184,449
184,449207,000203,000182,000190,000143,173142,759150,577168,000136,643131,045123,827162,000146,628131,015122,468158,000118,809121,00098,686111,05597,12576,99471,12482,31448,93058,03525,93322,25215,23617,25040,40333,02829,06639,91413,15425,8848,3538,5679,81426,6537,3725,7868,07415,3707,8005,7247,4175,4157,5537,6137,3767,0586,3097,0236,7918,1478,0046,4396,51420,5476,9887,1136,3784,6044,2294,2387,3639,6146,4616,8307,9186,6007,4597,2608,5748,9568,2369,2817,6867,4058,3806,7335,7684,8313,66611,3106,4386,4383,0022,5452,9932,5961,1451,2109271,0009009,30023,30032,10037,60048,30044,00051,10041,30036,70047,00042,30036,90044,70054,30032,50035,40018,70022,50032,10031,30032,20025,20021,90022,10021,10022,10022,00029,80037,60039,3001,80015,1003,400600100000
   > Long-term Assets 
0
0
0
2,400
2,800
6,500
7,200
10,800
13,200
14,200
16,300
17,000
18,100
19,600
20,400
23,200
21,900
21,700
21,900
21,600
21,100
20,800
20,300
20,600
21,800
21,400
22,200
21,900
24,600
26,500
27,100
28,700
29,500
30,400
31,200
32,900
34,000
44,300
45,600
43,900
54,119
50,836
47,803
50,052
47,177
76,587
74,111
0
88,245
94,770
104,880
118,503
120,432
98,902
98,304
95,381
103,845
97,670
95,916
82,816
78,657
74,159
63,140
60,515
59,906
53,645
50,845
49,704
53,837
52,478
51,616
51,541
52,573
54,219
55,149
55,766
60,814
61,649
61,331
61,058
69,308
69,466
68,308
67,340
68,547
118,852
128,696
124,755
123,194
121,975
124,095
122,248
121,132
119,590
118,612
111,646
112,563
111,980
112,640
119,212
120,006
120,806
119,744
119,102
111,909
113,138
113,257
114,535
121,624
126,472
141,448
154,040
156,277
164,043
168,689
459,898
461,940
463,000
486,898
512,000
532,868
547,763
558,720
260,000
259,133
258,651
259,153
267,000
265,968
264,985
269,845
331,000
342,000
355,000
349,000
348,219
348,219349,000355,000342,000331,000269,845264,985265,968267,000259,153258,651259,133260,000558,720547,763532,868512,000486,898463,000461,940459,898168,689164,043156,277154,040141,448126,472121,624114,535113,257113,138111,909119,102119,744120,806120,006119,212112,640111,980112,563111,646118,612119,590121,132122,248124,095121,975123,194124,755128,696118,85268,54767,34068,30869,46669,30861,05861,33161,64960,81455,76655,14954,21952,57351,54151,61652,47853,83749,70450,84553,64559,90660,51563,14074,15978,65782,81695,91697,670103,84595,38198,30498,902120,432118,503104,88094,77088,245074,11176,58747,17750,05247,80350,83654,11943,90045,60044,30034,00032,90031,20030,40029,50028,70027,10026,50024,60021,90022,20021,40021,80020,60020,30020,80021,10021,60021,90021,70021,90023,20020,40019,60018,10017,00016,30014,20013,20010,8007,2006,5002,8002,400000
       Property Plant Equipment 
0
0
0
2,000
2,300
5,800
6,300
9,500
10,700
11,700
13,800
14,000
14,600
15,800
16,600
18,600
18,200
17,400
16,300
15,900
15,200
14,600
14,100
14,600
15,700
15,500
15,700
15,300
17,800
18,500
18,500
18,800
19,100
19,800
20,300
21,500
22,400
22,400
23,700
23,900
23,388
22,596
23,322
22,625
22,596
23,330
24,268
28,245
28,245
37,946
47,211
59,094
60,797
39,269
37,880
34,790
32,721
32,172
30,857
28,454
26,665
22,837
10,181
9,130
8,208
7,563
7,227
7,157
7,042
6,890
6,583
7,131
8,274
10,494
14,019
17,371
24,183
26,636
26,911
27,338
36,171
36,071
35,549
35,703
37,680
88,010
98,019
96,615
95,132
94,008
92,598
91,084
89,694
88,312
87,273
86,198
86,641
86,321
88,068
88,958
89,047
89,692
89,243
90,233
90,365
90,602
90,970
92,845
95,439
99,677
116,624
121,907
123,188
127,940
132,003
132,160
133,519
135,000
148,717
154,000
163,952
172,618
181,518
181,000
180,413
179,316
180,144
178,000
177,724
177,015
180,806
256,000
264,000
269,000
245,000
242,939
242,939245,000269,000264,000256,000180,806177,015177,724178,000180,144179,316180,413181,000181,518172,618163,952154,000148,717135,000133,519132,160132,003127,940123,188121,907116,62499,67795,43992,84590,97090,60290,36590,23389,24389,69289,04788,95888,06886,32186,64186,19887,27388,31289,69491,08492,59894,00895,13296,61598,01988,01037,68035,70335,54936,07136,17127,33826,91126,63624,18317,37114,01910,4948,2747,1316,5836,8907,0427,1577,2277,5638,2089,13010,18122,83726,66528,45430,85732,17232,72134,79037,88039,26960,79759,09447,21137,94628,24528,24524,26823,33022,59622,62523,32222,59623,38823,90023,70022,40022,40021,50020,30019,80019,10018,80018,50018,50017,80015,30015,70015,50015,70014,60014,10014,60015,20015,90016,30017,40018,20018,60016,60015,80014,60014,00013,80011,70010,7009,5006,3005,8002,3002,000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000010,00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
100
200
200
300
400
0
0
0
1,100
0
0
0
2,600
0
0
0
4,100
4,300
4,600
5,000
4,800
5,000
5,100
5,700
6,200
6,400
7,000
7,100
7,500
8,000
8,300
8,600
9,100
9,500
10,000
10,600
11,300
11,592
11,886
12,135
13,815
13,943
44,950
45,133
49,096
49,096
49,334
50,428
49,653
50,043
50,151
50,384
50,737
51,338
51,891
52,600
45,201
45,266
44,806
44,501
42,543
42,061
41,290
39,060
38,271
37,888
37,643
37,289
36,859
36,906
36,496
35,573
33,121
32,892
31,423
30,979
30,451
29,926
29,606
29,101
15,821
15,773
16,444
16,994
16,259
17,071
17,701
25,371
25,225
25,614
25,677
25,858
20,089
20,484
20,360
20,039
19,876
20,136
20,813
20,774
19,316
20,144
21,152
20,929
20,365
21,175
21,362
21,908
22,004
22,914
23,452
24,027
24,032
25,220
26,056
26,985
25,674
26,750
27,700
28,274
27,937
28,795
29,373
30,038
29,005
29,295
29,054
29,605
0
0
0
0
0
0000029,60529,05429,29529,00530,03829,37328,79527,93728,27427,70026,75025,67426,98526,05625,22024,03224,02723,45222,91422,00421,90821,36221,17520,36520,92921,15220,14419,31620,77420,81320,13619,87620,03920,36020,48420,08925,85825,67725,61425,22525,37117,70117,07116,25916,99416,44415,77315,82129,10129,60629,92630,45130,97931,42332,89233,12135,57336,49636,90636,85937,28937,64337,88838,27139,06041,29042,06142,54344,50144,80645,26645,20152,60051,89151,33850,73750,38450,15150,04349,65350,42849,33449,09649,09645,13344,95013,94313,81512,13511,88611,59211,30010,60010,0009,5009,1008,6008,3008,0007,5007,1007,0006,4006,2005,7005,1005,0004,8005,0004,6004,3004,1000002,6000001,100000400300200200100000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30,731
28,240
24,481
27,427
24,581
53,257
49,843
60,000
55,508
56,824
57,669
59,409
59,635
59,633
60,424
60,591
71,124
65,498
65,059
54,362
51,992
51,322
52,959
51,385
51,698
46,082
43,618
42,547
46,795
45,588
45,033
44,410
44,299
43,725
41,130
38,395
36,631
35,013
34,420
33,720
33,137
33,395
32,759
31,637
30,867
30,842
30,677
28,140
28,062
27,967
31,497
31,164
31,438
31,278
31,339
25,448
25,922
25,659
24,572
30,254
30,959
31,114
30,501
28,869
21,544
22,536
22,287
21,690
26,185
26,795
24,824
32,133
10,175
12,651
12,659
303,706
290,101
289,238
298,196
310,590
327,147
323,108
324,579
77,971
80,000
438,000
248,000
319,000
289,000
87,000
259,000
34,972
78,000
43,034
0
0
0043,03478,00034,972259,00087,000289,000319,000248,000438,00080,00077,971324,579323,108327,147310,590298,196289,238290,101303,70612,65912,65110,17532,13324,82426,79526,18521,69022,28722,53621,54428,86930,50131,11430,95930,25424,57225,65925,92225,44831,33931,27831,43831,16431,49727,96728,06228,14030,67730,84230,86731,63732,75933,39533,13733,72034,42035,01336,63138,39541,13043,72544,29944,41045,03345,58846,79542,54743,61846,08251,69851,38552,95951,32251,99254,36265,05965,49871,12460,59160,42459,63359,63559,40957,66956,82455,50860,00049,84353,25724,58127,42724,48128,24030,7310000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
290,796
277,247
276,360
284,997
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000284,997276,360277,247290,7960000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
2,600
6,200
10,100
9,300
14,500
14,400
15,100
15,600
15,700
14,300
14,200
16,700
20,300
17,200
16,600
19,400
20,600
19,700
20,300
26,900
23,700
27,200
25,800
24,900
42,900
46,800
57,100
55,900
83,000
76,700
104,900
94,900
100,300
98,600
100,500
103,400
102,300
103,957
107,266
110,610
116,890
118,896
141,600
176,382
193,962
193,962
256,855
253,958
283,206
280,820
258,021
260,032
267,764
265,172
268,351
272,910
280,558
279,798
270,715
173,342
163,708
158,787
156,454
154,172
158,005
270,473
201,041
202,819
248,615
327,949
509,228
476,940
469,902
421,836
403,344
375,753
355,119
315,286
344,122
322,149
305,935
278,239
317,355
318,960
313,460
319,935
318,080
315,404
362,920
351,870
387,570
480,470
468,766
460,514
450,917
449,031
698,029
679,582
675,938
742,591
755,315
717,657
699,896
703,947
812,902
882,190
875,260
854,893
903,305
912,459
1,429,879
1,407,769
1,480,624
1,448,469
1,421,000
1,397,023
1,548,000
1,520,502
1,484,155
1,489,317
1,547,000
1,567,987
1,914,395
1,884,357
1,840,000
1,809,518
1,831,407
1,827,610
1,961,000
2,398,000
2,543,000
2,619,000
2,603,386
2,603,3862,619,0002,543,0002,398,0001,961,0001,827,6101,831,4071,809,5181,840,0001,884,3571,914,3951,567,9871,547,0001,489,3171,484,1551,520,5021,548,0001,397,0231,421,0001,448,4691,480,6241,407,7691,429,879912,459903,305854,893875,260882,190812,902703,947699,896717,657755,315742,591675,938679,582698,029449,031450,917460,514468,766480,470387,570351,870362,920315,404318,080319,935313,460318,960317,355278,239305,935322,149344,122315,286355,119375,753403,344421,836469,902476,940509,228327,949248,615202,819201,041270,473158,005154,172156,454158,787163,708173,342270,715279,798280,558272,910268,351265,172267,764260,032258,021280,820283,206253,958256,855193,962193,962176,382141,600118,896116,890110,610107,266103,957102,300103,400100,50098,600100,30094,900104,90076,70083,00055,90057,10046,80042,90024,90025,80027,20023,70026,90020,30019,70020,60019,40016,60017,20020,30016,70014,20014,30015,70015,60015,10014,40014,5009,30010,1006,2002,600000
   > Total Current Liabilities 
0
0
0
1,500
2,800
5,500
4,800
7,300
7,200
7,500
8,500
9,000
7,600
7,100
8,500
11,500
8,900
8,700
9,800
11,300
10,800
11,800
18,900
19,000
21,900
20,900
19,900
23,100
27,000
23,500
21,800
26,600
20,000
33,000
21,000
22,500
19,600
18,200
17,600
15,000
12,659
12,762
14,280
14,636
14,441
25,934
36,449
48,247
48,247
47,294
58,898
75,950
67,159
55,208
59,639
45,557
39,643
42,132
42,897
43,416
36,062
26,053
23,905
23,793
20,845
20,281
19,436
25,139
101,941
25,178
29,966
62,205
80,260
127,111
117,683
124,698
136,460
127,861
114,719
111,444
92,095
105,214
100,916
105,890
94,399
91,980
83,542
76,112
61,707
55,063
51,601
74,322
70,295
86,995
103,278
97,812
100,836
100,816
107,325
115,332
100,288
102,132
122,198
148,876
124,495
111,081
106,892
133,784
170,580
191,760
177,647
224,741
212,643
248,619
260,238
280,294
252,473
241,000
231,777
273,000
258,025
231,341
244,571
290,000
295,105
293,825
279,778
241,000
228,450
267,811
283,454
312,000
764,000
798,000
917,000
448,090
448,090917,000798,000764,000312,000283,454267,811228,450241,000279,778293,825295,105290,000244,571231,341258,025273,000231,777241,000252,473280,294260,238248,619212,643224,741177,647191,760170,580133,784106,892111,081124,495148,876122,198102,132100,288115,332107,325100,816100,83697,812103,27886,99570,29574,32251,60155,06361,70776,11283,54291,98094,399105,890100,916105,21492,095111,444114,719127,861136,460124,698117,683127,11180,26062,20529,96625,178101,94125,13919,43620,28120,84523,79323,90526,05336,06243,41642,89742,13239,64345,55759,63955,20867,15975,95058,89847,29448,24748,24736,44925,93414,44114,63614,28012,76212,65915,00017,60018,20019,60022,50021,00033,00020,00026,60021,80023,50027,00023,10019,90020,90021,90019,00018,90011,80010,80011,3009,8008,7008,90011,5008,5007,1007,6009,0008,5007,5007,2007,3004,8005,5002,8001,500000
       Short-term Debt 
0
0
0
300
400
3,200
3,400
1,000
5,100
5,500
6,400
6,100
2,300
2,600
2,900
4,900
4,500
4,100
2,500
2,400
2,100
2,000
1,900
5,000
5,100
5,000
5,100
6,200
6,000
1,600
1,500
2,300
2,200
2,200
2,200
3,600
3,600
3,600
4,000
3,900
3,767
3,723
3,538
4,607
4,400
12,766
27,494
9,837
9,837
9,737
10,465
21,435
20,602
20,332
42,782
16,477
10,355
10,260
10,029
10,546
9,674
9,106
8,314
7,835
7,863
7,742
7,684
7,514
88,307
7,474
7,457
7,238
5,471
3,669
9,935
2,065
2,876
2,995
4,106
4,270
4,020
4,977
5,138
5,645
5,145
4,911
4,157
3,390
2,941
5,313
5,182
4,879
4,508
4,853
4,649
4,408
4,308
4,207
3,667
2,882
2,058
1,225
773
9,029
8,826
8,608
49
1,185
56
21,476
60
1,621
47
1,164
14,472
13,749
14,500
14,432
2,060
2,026
4,150
4,966
5,849
293,161
61,816
61,876
61,936
3,526
4,206,000
4,732,000
4,970
7,535
8,239
24,732
31,070
53,163
53,16331,07024,7328,2397,5354,9704,732,0004,206,0003,52661,93661,87661,816293,1615,8494,9664,1502,0262,06014,43214,50013,74914,4721,164471,6216021,476561,185498,6088,8269,0297731,2252,0582,8823,6674,2074,3084,4084,6494,8534,5084,8795,1825,3132,9413,3904,1574,9115,1455,6455,1384,9774,0204,2704,1062,9952,8762,0659,9353,6695,4717,2387,4577,47488,3077,5147,6847,7427,8637,8358,3149,1069,67410,54610,02910,26010,35516,47742,78220,33220,60221,43510,4659,7379,8379,83727,49412,7664,4004,6073,5383,7233,7673,9004,0003,6003,6003,6002,2002,2002,2002,3001,5001,6006,0006,2005,1005,0005,1005,0001,9002,0002,1002,4002,5004,1004,5004,9002,9002,6002,3006,1006,4005,5005,1001,0003,4003,200400300000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,882
0
0
0
9,029
8,826
8,608
49
1,185
56
604,133
60
1,621
47
1,164
14,472
13,749
14,500
14,432
2,060
2,026
4,150
4,966
5,849
300,462
69,504
69,848
65,045
3,526
0
0
0
7,535
0
0
0
53,163
53,1630007,5350003,52665,04569,84869,504300,4625,8494,9664,1502,0262,06014,43214,50013,74914,4721,164471,62160604,133561,185498,6088,8269,0290002,882000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
400
1,300
400
1,200
1,300
800
600
1,000
600
500
900
1,400
900
1,000
1,300
1,500
1,400
600
800
1,000
1,100
700
900
2,400
2,400
1,400
1,100
2,800
1,200
2,700
2,800
3,000
2,700
2,700
1,800
3,100
1,302
1,134
732
2,231
3,328
2,805
2,949
6,126
6,126
3,197
11,382
5,524
2,889
3,781
2,171
3,720
3,349
3,416
2,818
6,967
2,240
2,297
2,833
2,095
2,483
3,267
3,003
4,288
3,274
4,161
4,507
4,507
5,633
5,716
6,885
5,710
7,445
6,659
5,554
4,696
4,843
5,355
3,392
6,523
4,652
3,071
6,653
8,300
5,344
6,194
5,256
10,239
5,385
9,461
8,781
11,009
9,869
13,453
15,627
17,984
16,487
10,954
19,294
28,355
19,464
17,583
15,680
21,120
23,237
13,268
23,525
24,886
13,833
13,291
13,576
28,660
13,332
15,628
13,146
16,067
21,174
7,407
16,222
17,199
9,506
14,658
8,357
11,904
16,125
10,351
20,545
17,921
10,499
24,021
5,615
26,027
26,0275,61524,02110,49917,92120,54510,35116,12511,9048,35714,6589,50617,19916,2227,40721,17416,06713,14615,62813,33228,66013,57613,29113,83324,88623,52513,26823,23721,12015,68017,58319,46428,35519,29410,95416,48717,98415,62713,4539,86911,0098,7819,4615,38510,2395,2566,1945,3448,3006,6533,0714,6526,5233,3925,3554,8434,6965,5546,6597,4455,7106,8855,7165,6334,5074,5074,1613,2744,2883,0033,2672,4832,0952,8332,2972,2406,9672,8183,4163,3493,7202,1713,7812,8895,52411,3823,1976,1266,1262,9492,8053,3282,2317321,1341,3023,1001,8002,7002,7003,0002,8002,7001,2002,8001,1001,4002,4002,4009007001,1001,0008006001,4001,5001,3001,0009001,4009005006001,0006008001,3001,2004001,3004000000
       Other Current Liabilities 
0
0
0
1,200
2,000
1,000
1,000
5,100
800
1,200
1,500
1,900
4,700
4,000
4,700
5,200
3,500
3,600
6,000
7,400
7,300
9,200
16,200
13,000
15,700
15,200
13,900
14,500
18,600
20,500
19,200
21,500
16,600
28,100
16,000
15,900
13,300
11,900
11,800
8,000
7,590
7,905
10,010
7,798
3,806
4,486
-14,051
32,284
9,588
13,140
16,672
15,317
13,071
11,453
-1,397
14,684
10,107
10,933
14,249
11,713
13,713
9,724
11,348
12,349
9,388
8,560
8,178
12,293
9,317
7,473
10,198
17,255
11,205
16,219
1,069
24,261
40,558
36,115
28,118
26,797
12,342
17,614
15,118
19,220
11,210
15,279
20,304
27,838
19,102
20,558
17,736
23,279
25,158
32,272
33,871
34,260
32,231
31,596
36,304
39,871
29,157
31,668
33,995
44,170
32,510
26,417
34,624
60,199
39,137
46,176
49,149
91,769
78,636
73,575
75,045
77,629
79,795
73,940
78,964
136,907
111,890
118,567
118,069
-128,360
117,043
115,219
111,560
127,570
-4,085,112
-4,567,933
158,428
195,544
653,262
653,247
675,315
217,772
217,772675,315653,247653,262195,544158,428-4,567,933-4,085,112127,570111,560115,219117,043-128,360118,069118,567111,890136,90778,96473,94079,79577,62975,04573,57578,63691,76949,14946,17639,13760,19934,62426,41732,51044,17033,99531,66829,15739,87136,30431,59632,23134,26033,87132,27225,15823,27917,73620,55819,10227,83820,30415,27911,21019,22015,11817,61412,34226,79728,11836,11540,55824,2611,06916,21911,20517,25510,1987,4739,31712,2938,1788,5609,38812,34911,3489,72413,71311,71314,24910,93310,10714,684-1,39711,45313,07115,31716,67213,1409,58832,284-14,0514,4863,8067,79810,0107,9057,5908,00011,80011,90013,30015,90016,00028,10016,60021,50019,20020,50018,60014,50013,90015,20015,70013,00016,2009,2007,3007,4006,0003,6003,5005,2004,7004,0004,7001,9001,5001,2008005,1001,0001,0002,0001,200000
   > Long-term Liabilities 
0
0
0
1,100
3,400
4,600
4,500
7,200
7,200
7,600
7,100
6,700
6,700
7,100
8,200
8,800
8,300
7,900
9,600
9,300
8,900
8,500
8,000
4,700
5,300
4,900
5,000
19,800
19,800
33,600
34,100
56,400
56,700
71,900
73,900
77,800
79,000
82,300
85,800
87,300
91,298
94,504
96,330
102,254
104,455
115,666
139,933
0
145,715
209,561
195,060
207,256
213,661
202,813
200,393
222,207
225,529
226,219
230,013
237,142
243,736
244,662
149,437
139,915
137,942
136,173
134,736
132,866
168,532
175,863
172,853
186,410
247,689
382,117
359,257
345,204
285,376
275,483
261,034
243,675
223,191
238,908
221,233
200,045
183,840
225,375
235,418
237,348
258,228
263,017
263,803
288,598
281,575
300,575
377,192
370,954
359,678
350,101
341,706
582,697
579,294
573,806
620,393
606,439
593,162
588,815
597,055
679,118
711,610
683,500
677,246
678,564
699,816
1,181,260
1,147,531
1,200,330
1,195,996
1,180,000
1,165,246
1,275,000
1,262,477
1,252,814
1,244,746
1,257,000
1,272,882
1,620,570
1,604,579
1,599,000
1,581,068
1,563,596
1,544,156
1,649,000
1,634,000
1,745,000
1,702,000
2,155,296
2,155,2961,702,0001,745,0001,634,0001,649,0001,544,1561,563,5961,581,0681,599,0001,604,5791,620,5701,272,8821,257,0001,244,7461,252,8141,262,4771,275,0001,165,2461,180,0001,195,9961,200,3301,147,5311,181,260699,816678,564677,246683,500711,610679,118597,055588,815593,162606,439620,393573,806579,294582,697341,706350,101359,678370,954377,192300,575281,575288,598263,803263,017258,228237,348235,418225,375183,840200,045221,233238,908223,191243,675261,034275,483285,376345,204359,257382,117247,689186,410172,853175,863168,532132,866134,736136,173137,942139,915149,437244,662243,736237,142230,013226,219225,529222,207200,393202,813213,661207,256195,060209,561145,7150139,933115,666104,455102,25496,33094,50491,29887,30085,80082,30079,00077,80073,90071,90056,70056,40034,10033,60019,80019,8005,0004,9005,3004,7008,0008,5008,9009,3009,6007,9008,3008,8008,2007,1006,7006,7007,1007,6007,2007,2004,5004,6003,4001,100000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,620
4,304
5,720
4,938
5,465
4,724
215,450
217,359
225,739
221,279
221,942
222,759
225,391
226,186
228,164
228,923
229,714
231,092
454,900
460,211
465,678
471,293
397,575
395,455
401,673
408,010
500,635
508,411
516,539
584,494
592,882
601,424
610,135
619,009
628,057
637,275
646,675
656,251
769,957
779,592
789,181
798,931
515,703
847,973
1,218,641
1,220,064
1,221,146
1,222,220
1,223,307
1,224,393
1,175,593
1,176,889
1,298,827
0
0
001,298,8271,176,8891,175,5931,224,3931,223,3071,222,2201,221,1461,220,0641,218,641847,973515,703798,931789,181779,592769,957656,251646,675637,275628,057619,009610,135601,424592,882584,494516,539508,411500,635408,010401,673395,455397,575471,293465,678460,211454,900231,092229,714228,923228,164226,186225,391222,759221,942221,279225,739217,359215,4504,7245,4654,9385,7204,3045,620000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
290,796
277,247
276,360
284,997
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000284,997276,360277,247290,7960000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,282
20,005
18,472
17,900
16,220
14,363
13,710
12,592
11,003
8,810
5,971
2,186
644
531
378
230
7,592
0
0
0
0
44
143
9,310
8,131
23,548
85,189
214,202
191,279
205,185
154,293
143,376
125,237
107,097
81,584
94,234
75,900
51,283
33,791
24,115
22,560
21,898
40,869
37,278
42,524
66,656
58,816
75,184
151,006
142,790
130,755
120,387
110,614
127,797
119,083
108,128
149,100
134,306
123,084
112,436
101,831
91,198
115,759
100,843
79,656
72,708
85,446
556,586
523,384
567,359
542,416
516,584
492,979
490,060
467,842
448,576
429,931
424,000
402,000
379,874
363,000
352,000
333,138
315,000
295,000
287,768
778,000
764,572
0
0
00764,572778,000287,768295,000315,000333,138352,000363,000379,874402,000424,000429,931448,576467,842490,060492,979516,584542,416567,359523,384556,58685,44672,70879,656100,843115,75991,198101,831112,436123,084134,306149,100108,128119,083127,797110,614120,387130,755142,790151,00675,18458,81666,65642,52437,27840,86921,89822,56024,11533,79151,28375,90094,23481,584107,097125,237143,376154,293205,185191,279214,20285,18923,5488,1319,3101434400007,5922303785316442,1865,9718,81011,00312,59213,71014,36316,22017,90018,47220,00516,2820000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
90,164
70,900
50,413
32,065
21,356
19,415
17,474
35,469
31,715
36,961
66,656
58,816
75,184
151,006
142,790
130,755
120,387
110,614
127,797
119,083
108,128
149,100
134,306
123,084
112,436
101,831
91,198
115,759
100,843
79,656
72,708
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000072,70879,656100,843115,75991,198101,831112,436123,084134,306149,100108,128119,083127,797110,614120,387130,755142,790151,00675,18458,81666,65636,96131,71535,46917,47419,41521,35632,06550,41370,90090,164000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
1,700
12,800
33,500
31,100
59,100
54,100
49,900
45,100
39,800
52,900
48,200
43,700
58,500
63,100
57,300
51,900
46,000
40,500
38,000
53,600
75,900
71,500
65,800
60,000
58,400
51,000
42,000
41,400
34,900
24,600
12,700
11,900
-4,200
-15,700
-5,200
-9,300
800
47,887
69,758
65,965
66,366
44,468
45,928
118,030
223,099
223,099
186,371
170,566
155,477
134,275
112,835
93,514
67,178
47,554
11,611
-17,639
-72,133
-104,150
-124,189
4,040
2,665
-8,150
6,713
1,577
68,563
56,898
47,284
232
872
54,621
59,023
68,078
67,092
288,846
292,851
304,825
291,722
284,437
262,229
253,709
244,542
227,703
212,217
186,825
171,434
150,872
154,314
170,277
182,766
201,091
401,081
401,446
378,390
374,102
366,860
344,772
257,780
275,851
300,320
245,414
200,790
158,162
111,213
139,639
99,565
201,806
215,571
307,968
330,872
301,391
696,255
710,550
1,048,079
1,207,651
1,269,000
1,336,293
1,471,000
1,360,239
1,377,175
1,383,149
843,000
680,564
582,674
530,536
772,000
709,574
624,726
594,361
573,000
487,000
428,000
315,000
386,686
386,686315,000428,000487,000573,000594,361624,726709,574772,000530,536582,674680,564843,0001,383,1491,377,1751,360,2391,471,0001,336,2931,269,0001,207,6511,048,079710,550696,255301,391330,872307,968215,571201,80699,565139,639111,213158,162200,790245,414300,320275,851257,780344,772366,860374,102378,390401,446401,081201,091182,766170,277154,314150,872171,434186,825212,217227,703244,542253,709262,229284,437291,722304,825292,851288,84667,09268,07859,02354,62187223247,28456,89868,5631,5776,713-8,1502,6654,040-124,189-104,150-72,133-17,63911,61147,55467,17893,514112,835134,275155,477170,566186,371223,099223,099118,03045,92844,46866,36665,96569,75847,887800-9,300-5,200-15,700-4,20011,90012,70024,60034,90041,40042,00051,00058,40060,00065,80071,50075,90053,60038,00040,50046,00051,90057,30063,10058,50043,70048,20052,90039,80045,10049,90054,10059,10031,10033,50012,8001,700000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-12,300
-12,400
35
38
38
40
40
42
47
54
54
54
56
55
55
55
56
56
56
57
57
57
58
58
72
72
73
73
74
82
82
82
87
87
93
95
96
97
98
98
98
99
99
99
99
99
100
100
100
100
100
100
102
102
103
114
116
116
118
118
118
118
120
120
120
120
121
121
121
122
124
124
125
125
125
137
138
138
140
140
141
140
139
139
140
140
141
141
141
141
142
142
142
142
143
143
143
144
1441431431431421421421421411411411411401401391391401411401401381381371251251251241241221211211211201201201201181181181181161161141031021021001001001001001009999999999989898979695938787828282747373727258585757575656565555555654545447424040383835-12,400-12,30000000000000000000000000000000000000000
   Retained Earnings Total Equity00-1,639,238-1,553,948-1,429,625-1,377,195-1,330,203-1,225,068-1,159,903-1,384,516-1,302,050-1,221,175-1,249,368-909,098-878,154-846,309-707,534-857,563-883,726-882,850-967,293-1,287,369-1,282,809-1,242,454-1,187,398-1,190,144-1,189,167-1,177,960-1,181,428-1,207,293-1,214,644-1,157,789-1,094,872-1,023,439-987,663-1,023,311-1,006,594-1,037,647-1,010,971-998,890-967,610-943,334-918,764-908,638-906,966-904,329-866,690-865,483-841,488-821,452-794,570-776,681-756,687-742,701-730,247000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-13,100
-15,600
-15,600
-15,600
-15,600
-18,500
-18,500
-18,500
-18,500
-22,300
-22,300
-22,300
-22,300
-26,700
42
-26
-1,324
-732
191
240
719
-34,452
415
-622
-24
-667
1,580
2,846
4,113
3,182
4,294
-2,353
816
2,551
536
132
2,348
3,178
5,739
2,114
2,045
4,278
2,081
418
511
538
2,123
2,730
-1,271
982
473
2,324
3,678
2,153
1,379
941
1,162
949
689
399
-1,153
-770
-242
968
846
12,480
17,784
26,986
29,021
21,080
29,000
24,719
16,894
39,747
47,114
18,411
-17,957
-13,565
-16,115
-26,853
-26,498
-30,358
-30,460
-30,372
-30,199
-31,759
-33,234
-32,634
-32,532
-32,016
-27,608
-24,252
-25,375
-25,290
-27,235
-16,440
-19,572
-21,071
-24,203
-25,796
-27,437
-32,668
-48,578
-54,007
-63,140
-57,480
-48,983
-50,913
-46,037
-32,645
-32,645-46,037-50,913-48,983-57,480-63,140-54,007-48,578-32,668-27,437-25,796-24,203-21,071-19,572-16,440-27,235-25,290-25,375-24,252-27,608-32,016-32,532-32,634-33,234-31,759-30,199-30,372-30,460-30,358-26,498-26,853-16,115-13,565-17,95718,41147,11439,74716,89424,71929,00021,08029,02126,98617,78412,480846968-242-770-1,1533996899491,1629411,3792,1533,6782,324473982-1,2712,7302,1235385114182,0814,2782,0452,1145,7393,1782,3481325362,551816-2,3534,2943,1824,1132,8461,580-667-24-622415-34,452719240191-732-1,324-2642-26,700-22,300-22,300-22,300-22,300-18,500-18,500-18,500-18,500-15,600-15,600-15,600-15,600-13,10000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
991,436
995,149
1,000,181
1,003,595
1,006,288
1,009,330
1,013,592
1,016,497
1,019,936
1,073,658
1,077,150
1,091,842
1,292,745
1,315,643
1,324,804
1,343,874
1,352,994
1,365,407
1,224,509
1,251,928
1,269,452
1,286,690
1,309,107
1,331,945
1,352,589
1,373,309
1,311,229
1,410,102
1,434,986
1,528,186
1,549,904
1,576,954
2,011,561
2,030,313
2,047,250
2,117,969
2,177,222
2,219,090
2,203,778
2,233,644
2,271,630
2,311,679
2,113,646
1,925,801
1,910,379
1,942,348
1,964,167
1,983,078
2,008,794
2,034,554
2,059,850
2,089,358
2,118,309
0
0
002,118,3092,089,3582,059,8502,034,5542,008,7941,983,0781,964,1671,942,3481,910,3791,925,8012,113,6462,311,6792,271,6302,233,6442,203,7782,219,0902,177,2222,117,9692,047,2502,030,3132,011,5611,576,9541,549,9041,528,1861,434,9861,410,1021,311,2291,373,3091,352,5891,331,9451,309,1071,286,6901,269,4521,251,9281,224,5091,365,4071,352,9941,343,8741,324,8041,315,6431,292,7451,091,8421,077,1501,073,6581,019,9361,016,4971,013,5921,009,3301,006,2881,003,5951,000,181995,149991,436000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
8,900
21,200
40,700
44,000
75,200
75,200
75,300
75,400
75,400
93,500
93,600
93,800
113,200
119,400
118,700
118,700
118,800
119,200
122,600
145,100
172,400
173,100
174,700
188,000
197,100
198,200
198,600
200,200
207,500
208,800
210,700
210,900
215,200
216,300
243,500
251,900
284,300
298,449
334,687
337,600
352,854
352,880
377,333
461,267
0
582,258
585,404
600,716
602,101
602,974
603,364
604,978
604,948
610,517
622,106
622,395
623,706
623,361
623,385
764,555
770,263
774,366
795,026
802,063
880,954
884,506
887,579
820,422
827,992
884,434
890,435
900,303
905,721
967,648
972,697
978,411
985,620
988,053
991,436
995,149
1,000,181
1,003,595
1,006,288
1,009,330
1,013,592
1,016,497
1,019,936
1,073,658
1,077,150
1,091,842
1,292,745
1,315,643
1,324,804
1,343,874
1,352,994
1,365,407
1,224,509
1,251,928
1,269,452
1,286,690
1,309,107
1,331,945
1,352,589
1,373,309
1,311,229
1,410,102
1,434,986
1,528,186
1,549,904
1,576,954
2,011,561
2,030,313
2,047,250
2,117,969
2,177,222
2,219,090
2,203,778
2,233,644
2,271,630
2,311,679
2,113,646
1,925,801
1,910,379
1,942,348
1,964,167
1,983,078
2,008,794
2,034,554
2,059,963
2,089,788
2,118,008
2,147,542
2,182,453
2,182,4532,147,5422,118,0082,089,7882,059,9632,034,5542,008,7941,983,0781,964,1671,942,3481,910,3791,925,8012,113,6462,311,6792,271,6302,233,6442,203,7782,219,0902,177,2222,117,9692,047,2502,030,3132,011,5611,576,9541,549,9041,528,1861,434,9861,410,1021,311,2291,373,3091,352,5891,331,9451,309,1071,286,6901,269,4521,251,9281,224,5091,365,4071,352,9941,343,8741,324,8041,315,6431,292,7451,091,8421,077,1501,073,6581,019,9361,016,4971,013,5921,009,3301,006,2881,003,5951,000,181995,149991,436988,053985,620978,411972,697967,648905,721900,303890,435884,434827,992820,422887,579884,506880,954802,063795,026774,366770,263764,555623,385623,361623,706622,395622,106610,517604,948604,978603,364602,974602,101600,716585,404582,2580461,267377,333352,880352,854337,600334,687298,449284,300251,900243,500216,300215,200210,900210,700208,800207,500200,200198,600198,200197,100188,000174,700173,100172,400145,100122,600119,200118,800118,700118,700119,400113,20093,80093,60093,50075,40075,40075,30075,20075,20044,00040,70021,2008,900000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue787,647
Cost of Revenue-9,133
Gross Profit778,514778,514
 
Operating Income (+$)
Gross Profit778,514
Operating Expense-1,132,225
Operating Income-353,730-353,711
 
Operating Expense (+$)
Research Development899,625
Selling General Administrative232,600
Selling And Marketing Expenses0
Operating Expense1,132,2251,132,225
 
Net Interest Income (+$)
Interest Income0
Interest Expense-75,597
Other Finance Cost-5,900
Net Interest Income-81,497
 
Pretax Income (+$)
Operating Income-353,730
Net Interest Income-81,497
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-333,965-454,952
EBIT - interestExpense = -420,931
-333,965
-290,689
Interest Expense75,597
Earnings Before Interest and Taxes (EBIT)-345,334-258,368
Earnings Before Interest and Taxes (EBITDA)-322,836
 
After tax Income (+$)
Income Before Tax-333,965
Tax Provision-32,321
Net Income From Continuing Ops-366,286-366,286
Net Income-366,286
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses1,141,358
Total Other Income/Expenses Net101,22281,497
 

Technical Analysis of Ionis Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ionis Pharmaceuticals Inc. The general trend of Ionis Pharmaceuticals Inc is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ionis Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Ionis Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 47.66 < 47.93 < 48.05.

The bearish price targets are: 41.85 > 41.84 > 41.60.

Tweet this
Ionis Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Ionis Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Ionis Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Ionis Pharmaceuticals Inc. The current macd is -0.79998392.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Ionis Pharmaceuticals Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Ionis Pharmaceuticals Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Ionis Pharmaceuticals Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Ionis Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartIonis Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Ionis Pharmaceuticals Inc. The current adx is 15.86.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Ionis Pharmaceuticals Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Ionis Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Ionis Pharmaceuticals Inc. The current sar is 41.79.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Ionis Pharmaceuticals Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Ionis Pharmaceuticals Inc. The current rsi is 43.38. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Ionis Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartIonis Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Ionis Pharmaceuticals Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ionis Pharmaceuticals Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Ionis Pharmaceuticals Inc Daily Stochastic Oscillator ChartIonis Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Ionis Pharmaceuticals Inc. The current cci is 23.12.

Ionis Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartIonis Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Ionis Pharmaceuticals Inc. The current cmo is -8.15680922.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Ionis Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartIonis Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Ionis Pharmaceuticals Inc. The current willr is -47.76261978.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Ionis Pharmaceuticals Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Ionis Pharmaceuticals Inc Daily Williams %R ChartIonis Pharmaceuticals Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Ionis Pharmaceuticals Inc.

Ionis Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Ionis Pharmaceuticals Inc. The current atr is 1.24028083.

Ionis Pharmaceuticals Inc Daily Average True Range (ATR) ChartIonis Pharmaceuticals Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Ionis Pharmaceuticals Inc. The current obv is 8,947,075.

Ionis Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartIonis Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Ionis Pharmaceuticals Inc. The current mfi is 44.75.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Ionis Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartIonis Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Ionis Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Ionis Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Ionis Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.380
Ma 20Greater thanMa 5043.513
Ma 50Greater thanMa 10046.682
Ma 100Greater thanMa 20048.287
OpenGreater thanClose44.950
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Ionis Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Ionis Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ionis Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Ionis Pharmaceuticals Inc

I send you an email if I find something interesting about Ionis Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Ionis Pharmaceuticals Inc.

Receive notifications about Ionis Pharmaceuticals Inc in your mailbox!